FURTHER EVIDENCE CONCERNING THE AUTOANTIGENIC STATUS OF THE TROPHOBLAST by Beer, Alan E. et al.
FURTHER  EVIDENCE  CONCERNING  THE  AUTOANTIGENIC 
STATUS  OF  THE  TROPHOBLAST* 
BY ALAN E.  BEER, R.  E.  BILLINGHAM, AND S. L. YANG:~ 
(From the Department qf Cell Biology,  The  University  qf Texas Southwestern  Medical 
School at Dallas,  Dallas,  Texas 75235) 
(Received for publication 17 January 1972) 
Interest  in the possibility  that  the placenta  contains organ-specific antigens  was 
stimulated at the beginning of the century by the suggestion that some toxemias of 
pregnancy might result from maternal sensitization against placental antigens, leading 
secondarily to renal damage (1). 
The  general principle  that  an  antiserum  raised  in  one  species  against  placental 
homogenates from a  different species  will  interrupt pregnancy in individuals  of the 
species  that provided the antigen has been well  established  since  Dobrowolski's (2) 
work  with  guinea pigs  and  rabbits  (see  reference  3).  Contaminating  erythrocytes 
have been exonerated as the effective  antigens and the strong nephrotoxic activity of 
many anti-placental sera established  (4-6). However, it seems fairly well documented 
that potent nephrotoxic anti-kidney sera are not necessarily placentotoxic  (7,  8). 
The nature and distribution of the antigens apparently shared in common by the 
placenta and kidney have been subjected to repeated investigations mainly of an in 
vitro nature  (6,  8-13). These  have strongly implicated  trophoblast as the principal 
source of the shared antigens, but failed to produce unequivocal evidence of the exist- 
ence of antigens restricted to trophoblast. 
The  findings  of heterotopic  transplantation  studies  on  ectoplacental  cones 
and blastocysts in mice by Hulka and M oAr (14) and particularly by Kirby (15 ), 
have recently strengthened  belief in trophoblast-specific  antigens.  The experi- 
ments that form the subject matter of this communication, designed to evaluate 
the abortifacient activity, in pregnant rats, of antisera raised in rabbits against 
trophoblast,  fetal,  and various adult rat tissues,  both before and after appro- 
priate absorptions,  have yielded results strongly favoring the existence  of this 
antigen (or antigens). 
Materials and Methods 
Rats.--Rats of the isogenic Fischer (FI) 1 strain provided the subjects for most of the work 
described. 
Rabbits.--The  rabbits used as antibody producers were adult white New Zealand males. 
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Trophoblast Cells.--Trophoblast  cells for use as" antigen" were prepared from rat placentas 
of 12-14 days of gestation. Mter stripping the membranes from their fetal surfaces the pla- 
centas were thoroughly washed with Hanks' solution, minced finely with scissors, and gently 
pressed through a  50-mesh stainless steel sieve. The resulting crude tissue suspension was 
washed twice in large volumes of Hanks' solution containing penicillin, 10,000 units/ml, strep- 
tomycin, 10,000  #g/ml, and Fungizone, 25 #g/ml, (Grand Island Biological Co., Grand Island 
N. Y.), and resuspended at a concentration of approximately 1 organ equivalent/ml. Centrif- 
ugation at 1200 g for 10 min sedimented the principal cell types present in three distinct layers: 
leukocytes at the top,  erythrocytes at the bottom, and a  fairly- homogeneous population of 
monodisperse trophoblast cells in the middle. The latter were removed, resuspended in Hanks' 
solution, and counted in a hemocytometer, using the trypan blue exclusion method to assay 
viability. Examination of these suspensions by phase-contrast microscopy and of the stained 
smear preparations by light microscopy revealed that about 90% of the cells present were of 
trophoblastic origin. For immunization purposes, the concentration of all cell suspensions was 
adjusted so that they contained 50 X  106 viable cells/0.5 ml. 
Suspensions of Viable Epidermal Cells.--Suspensions  were prepared enzymically from tall 
skin by Silvers and Billingham's (16) procedure. 
Suspensions  of Adult Spleen Cells,  Thymocytes, and  "Fetal"  Cells.--Suspensions  of  cells 
(from whole fetuses of 10-12 days' gestation and excluding all placental and umbilical cord mate- 
rial) were prepared by our standard methods (17). In all instances excised tissues and cell sus- 
pensions were prepared and kept at about 5°C. 
Production of Heterologous A ntisera.--Production  followed an immunization protocol which 
was essentially that which has proved satisfactory in raising a biologically active anti-lympho- 
cyte serum (ALS)  (18). 
0.5 ml aliquots of the appropriate type of cell suspension were mixed with equal volumes of 
Freund's complete adjuvant and injected into the hind footpads of rabbits. Booster injections 
of 100  X  l0  B viable ceils in Hanks' solution were injected intravenously 21 and 28 days later 
and the animals exsanguinated on day 35. The blood was allowed to stand for 2 hr at room 
temperature for clotting to occur, followed by 24 hr at 4°C before separation and heat inacti- 
vation of the serum. The latter was twice absorbed with 1 volume of washed Fischer rat eryth- 
rocytes, first at 4°C  and second at 37°C,  to remove all hemagglutinins. All anti-lymphocyte 
activity, determined by cytotoxicity testing using the trypan blue exclusion technique (19), 
was removed when necessary by subsequent absorption with suspensions of washed lymphoid 
cells prepared from lymph nodes and spleens. 
Assay cf Titers.--Assay and determination of the characteristics of the antibodies were ac- 
complished by the gel immunodiffusion method of Ouchterlony (20).  A saline extract of the 
antigen was prepared by homogenization of the trophoblast cells. After hemagglutinin absorp- 
tion, the standard anti-trophoblast antibody displayed a  precipitating band at a  dilution of 
1:256. 
Bioassay of Antisera.--Groups  of about six  time-mated and putatively pregnant females 
were segregated and treatment with the various antisera initiated at various stages of gestation. 
The standard treatment comprised a  total of 3 ml of antiserum, injected intramuscularly in 
1 ml subdoses on alternate days. The recipients were observed for vaginal bleeding and pal- 
pated under ether anesthesia on alternate days to assay fetal growth. Representative animals 
were killed at selected stages for gross and histological examination of fetal and maternal 
organs. 
OBSERVATIONS 
Influence  of  Rabbit  Anti-Rat  Antisera  on  _Pregnant  Rats  and  their  Concep- 
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in Table I. Whereas normal rabbit serum had no discernible adverse effect on 
either the mothers or their fetuses, anti-trophoblast  serum,  unabsorbed  with 
lymphoid cells,  aborted 12 out of 12 subjects and caused the deaths of two of 
them. 
Kirby (21)  has reported that rabbit anti-mouse lymphocyte serum is aborti- 
facient in mice. He attributed this to its luteolytic activity on the grounds that 
the  ALS  did  not  cause  abortion  if  progesterone  was  administered  concom- 
"FABLE I 
Effect of Rabbit  Antisera Against  Various  Types of Rat Cells on C,  ravid 
Females and Their Conceptuses 
Type 
Type of rabbit  Absorbed  with* 
antiserum* 
9  o  ~ 
Pregnant female 
recipients  Status 
and 
No.  No  No.  No. of 




Antl-trophoblast  Lymphoid cells 







Anti-trophoblast  Lymphoid ceils 
Rat: FI:~  X  FI  8  0  0  Normal 
Rat: FI  X  FI  12  12  2  None 
Rat: FI  X  FI  12  3  8  None 
Rat: DA  X  DA  0  None 
Rat: FI  X  DA  0  None 
Rat: BH  X  BH  4~ 46  46  0  None 
Rat: LE§  X  LE  il  -|  i/  0  None 
I Rat: BN  X  BN  0  None 
[Rat: S-DII  X  S-D  0  None 
Rat: FI  X  FI  10  0  0  Normal 
Rat: FI  N  FI  6 
Rat: FI  X  FI  6 
Rat: FI  X  FI  7 
Rat: FI  X  FI  6 
Mouse: C57  BL/6  X  C57 BL/6  4 
Mouse: A  X  A  4 
Hamster: MHA X  MHA  4 
Hamster: CB  X  CB  4 
0  0  Normal 
0  0  Normal 
0  0  Normal 
0  0  Normal 
0  0  Normal 
0  0  Normal 
0  0  Normal 
0  0  Normal 
* All antisera absorbed with rat erythrocytes to remove hemagglutinins. 
** FI =  Fischer. 
§ LE  =  Lewis. 
[J Sprague-Dawley rats of an outbred  strain. 
itantly. The influence of rabbit anti-rat ALS was therefore tested in pregnant 
Fischer rats. As shown in Table I, not only did this abort 25 % of the subjects 
but it also killed 67 %  of them. This observation raised the question whether 
the  abortifacient  potency  of  the  anti-trophoblast  serum  resided  in  an  anti- 
lymphocyte moiety (22). To investigate this possibility, anti-trophoblast serum 
was repeatedly absorbed with suspensions of lymphoid cells until cytotoxicity 
tests for the presence of anti-lymphocyte activity gave negative results. Admin- 
istration  of this  absorbed antiserum  to pregnant  Fischer  rats  aborted  12/12 
but  did not harm them or  interfere  with  their subsequent  reproductive  per- 
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Irrespective of the  stage  of gestation  at which lymphocyte-absorbed anti- 
trophoblast serum treatment was initiated, the first injection prompted vaginal 
bleeding from the pregnant recipients within 24 hr. Ill an additional group of 
15 treated animals killed and dissected after they had passed beyond their ex- 
pected date of delivery, fetuses at various stages of resorption were identified. 
Histological examination of placentas obtained from animals receiving anti- 
trophoblast serum absorbed with lymphoid ceils revealed areas of hemorrhage 
and necrosis as well as cellular infiltration of these organs by plasma cells, small 
lymphocytes, and polymorphs. The fetuses were edematous and macerated. No 
abnormalities  were  observed  either  grossly or  microscopically in  the  uteri, 
deciduae,  copora lutea, kidneys, lungs,  or livers of the mothers,  indicating  a 
high degree of tissue specificity. 
If the abortifacient activity of anti-trophoblast serum is due to an antibody 
corresponding to a  specific determinant(s)  associated with  trophoblast,  then 
this activity should be removable by repeated absorptions with viable tropho- 
blast  cells.  Accordingly  lymphoid  cell-absorbed  anti-trophoblast  serum  of 
proven potency was repeatedly absorbed with trophoblast cells until it no longer 
produced  precipitation  lines  against  a  saline  extract  of  trophoblast  cells  in 
immunodiffusion tests. 
On bioassy, this antiserum proved to be completely innocuous in l0 out of 10 
pregnant females, none of which showed vaginal bleeding and all of which de- 
livered healthy litters of normal size. 
The following additional findings (Table I) support the premise that an anti- 
body specifically reactive with a distinctive component of trophoblast, rather 
than with an antigenic determinant shared in common by a variety of cell types, 
is responsible for the abortifacient potency of anti-trophoblast serum: neither 
(a)  rabbit  anti-rat  epidermal  cell  serum  nor  (b)  rabbit  anti-rat  fetus  serum 
harmed either pregnant females or their fetuses. Unlike most previous investi- 
gators, however, we have been unable to demonstrate that our anti-trophoblast 
serum had any nephrotoxic effect on female rats or reacted with kidney antigen 
in immunodiffusion tests possibly because of the prior absorption with lympho- 
cytes. However, whereas rabbit antiserum of high titer prepared against  renal 
tissue was devoid of abortifacient activity in a  panel of 15 pregnant  females 
and failed to react with trophoblast cell extracts in immunodiffusion tests, it did 
cause histologic lesions  in the recipients' kidneys. 
Since the trophoblast cell preparations employed as antigen in this study were 
contaminated by decidual cells, the possibility remained that the active compo- 
nent of the anti-trophoblast antiserum was  in fact an anti-decidual or  anti- 
endometrial cell antibody. To test this possibility, an antiserum against decidual 
cells was raised in rabbits, absorbed with rat erythrocytes, and assayed ill preg- 
nant Fischer females. Its inability to harm them or their pregnancies dismissed 
the interpretation under consideration. 
Influence of Timing of Administration and Dosage of Heterologous Anti-Pla- ALAN  E.  BEER,  R.  E.  BILLINGtIAM,  AND  S.  L.  YANG  1181 
cental Serum on its Abortifacient Capacity.--To  define the period during gesta- 
tion when rat fetuses are susceptible to the activity of anti-trophoblast serum, 
the  standard  treatment with  lymphocyte-absorbed antibody was  initiated in 
panels of five to seven gravid females at 7-18 days postconception (Table II). 
Despite this great range of developmental age, all fetuses appeared to be at equal 
risk insofar as they were all aborted. 
Although no attempt was made to determine the minimal dose of antiserum 
required to procure abortion, in many instances it was found that a single 1 ml 
inoculation sufficed to terminate a pregnancy. 
Strain  and  Species Specificity.--Since  all  defined organ  and  tissue  specific 
antigens are shared in common by all members of the same species, irrespective 
of their genetic  constitutions,  and  frequently show cross-reactivity between 
related species,  the influence of administering lymphoid cell-absorbed rabbit 
anti-Fischer rat trophoblast serum to panels of pregnant rats of the following 
strains, BN, DA, Lewis, Black Hooded, and outbred Sprague-Dawley,  and  to 
TABLE II 
A bort~[acient Effect of Rabbit A nti-Trophoblast Serum at Varying Stages of G6station in the Rat 
Inception of antiserum 
therapy after conception  No. of gravid hosts tested  No. in which abortion or 
resorption procured 
Day 7  6  6 
Day 10  7  7 
Day 14  6  6 
Day 18  5  5 
mice and hamsters was studied (Table I). Whereas the antiserum proved equally 
effective in aborting rats, irrespective of the genetic constitution of their fetuses, 
it was without any perceptible effect on pregnant mice and  hamsters. 
Finally, we addressed ourselves to the important question as to whether rats 
are potentially capable of reacting against their own trophoblast antigens, i.e., 
whether trophoblast is potentially autoantigenic. Two experiments were per- 
formed. In the first, male Fischer rats were subjected to the standard immuniza- 
tion protocol, as described for rabbits, only in this case rats of the unrelated DA 
strain provided the trophoblast cells.  Alien strain donors were selected in the 
belief that foreign transplantation  antigens  on the  same cellular vehicle with 
which the putative trophoblast-specific antigen was associated might exert an 
adjuvant effect (see reference 23). Serum was harvested from these animals and 
administered to 10 pregnant Fischer females, following the standard regimen. 
In the second experiment, eight virgin female  Fischer rats were actively im- 
munized with DA rat trophoblast cells as described above and then mated with 
Fischer males. In both experiments treatment of the females failed to influence 
the normal development to term and subsequent health of their fetuses. 1182  AUTOANTIGENIC STATUS  OF  THE  TROPHOBLAST 
DISCUSSION 
The findings that rabbit anti-rat trophoblast serum, absorbed with rat eryth- 
rocytes and lymphocytes, has a powerful abortifacient influence in pregnant rats 
of a wide variety of strains, which can be removed completely by absorption 
with  trophoblast  cells  greatly  strengthens  the  thesis  that  there  is  a  highly 
tissue-specific or unique antigen associated with trophoblast. 
The  observation  that  the  abortifacient activity of  anti-trophoblast  serum 
can be removed by absorption with fairly pure suspensions  of intact,  viable 
trophoblast cells suggests that this antigen (or antigens) is present on cell sur- 
faces. In the light of Bagshawe's (24) finding that high dilutions of rabbit anti- 
sera  prepared  against  highly  purified  human  chorionic  gonadotrophin  were 
rapidly lethal to both human choriocarcinoma and normal trophoblast cells in 
vitro, the possibility must be borne in mind that the putative trophoblast cell- 
associated antigen may be a hormone produced by these cells, or absorbed from 
the serum by them. Indeed it could even be a hormone receptor. 
If subsequent experiments, using more sophisticated  immunological proce- 
dures,  substantiate  and extend the present conclusions  by  defining the anti- 
bodies and  the  distribution  and immunochemical  characteristics of  the  anti- 
gen(s), heterologous anti-trophoblast serum will merit clinical evaluation. Firstly 
it may serve as an abortifacient effective from very early  stages of pregnancy 
onwards, and secondly it may afford an  ancillary therapeutic agent in patients 
with choriocarcinoma, whose tumors have proved refractory to treatment with 
chemotherapeutic agents such as methotrexate and actinomycin D. The clinical 
application of heterologous ALS as an immunosuppressant has provided con- 
siderable information  about the  possible dangers  and probable systemic side 
effects of such an agent (25). 
SUMTI~fARY 
Heterologous antisera were raised by inoculation of rabbits with fairly pure 
suspensions of trophoblast, lymphoid, fetal (excluding placental components), 
epidermal,  decidual,  and  renal  cells  from  Fischer  rats.  After  absorption  of 
hemagglutinins, these antisera were assayed for abortifacient activity by intra- 
muscular inoculation into time-mated Fischer females. 
The anti-trophoblast serum aborted all  the  recipients,  but  had  some  non- 
specific activity in that it caused the deaths of 12 % of them. Anti-lymphocyte 
serum was more toxic and less potent as an abortifacient. Nolle of the other sera 
harmed either the mothers or their fetuses. However, the anti-kidney cell serum 
caused kidney lesions. 
Absorption  of  the  anti-trophoblast  serum  with  lymphoid  cells  completely 
removed its toxicity for the pregnant females without perceptible impairment 
of its abortifacient activity. However, the latter could be removed by absorption 
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(a)  The lymphocyte-absorbed anti-trophoblast  serum  was equally effective 
in aborting rats over the range 7-18 days pcstconception; (b) a single injection 
of 1 ml was sufficient in most cases,  and  (c)  it was equally efficacious in ter- 
minating gestation in rats irrespective of their genetic constitution,  and (d) its 
effect was highly species-specific. 
These findings support  the premise  that  a  unique  antigen  (or antigens),  of 
possible clinical significance,  is associated with  trophoblast  cells. 
The authors are deeply indebted to Dr. Charles F. Shaffer for advice relating to the produc- 
tion of the antisera, to Mr. Billy D. Sanders for his invaluable technical assistance, and to Dr. 
J. Wayne Streilein for helpful criticism. 
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